MIRA INFORM REPORT

 

 

Report Date :

19.04.2014

 

IDENTIFICATION DETAILS

 

Name :

WAKO PURE CHEMICAL INDUSTRIES LTD

 

 

Registered Office :

3-1-2 Doshomachi Chuoku Osaka 540-8605

 

 

Country :

Japan

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

June, 1922

 

 

Legal Form :

Limited Company (Kabushiki Kaisha)

 

 

Line of Business :

Manufacturing of laboratory chemicals, specialty chemicals, chemical diagnostics, reagents

 

 

No. of Employees :

1,490

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 


 

Status :

Satisfactory

Payment Behaviour :

No complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

Japan

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


 

JAPAN - ECONOMIC OVERVIEW

 

In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan's industrial sector is heavily dependent on imported raw materials and fuels. A small agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. While self-sufficient in rice production, Japan imports about 60% of its food on a caloric basis. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession three times since 2008. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake and the ensuing tsunami in March disrupted manufacturing. The economy has largely recovered in the two years since the disaster, but reconstruction in the Tohoku region has been uneven. Prime Minister Shinzo ABE has declared the economy his government's top priority; he has overturned his predecessor's plan to permanently close nuclear power plants and is pursuing an economic revitalization agenda of fiscal stimulus, monetary easing, and structural reform. Japan joined the Trans Pacific Partnership negotiations in 2013, a pact that would open Japan's economy to increased foreign competition and create new export opportunities for Japanese businesses. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2013 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. The new government will continue a longstanding debate on restructuring the economy and reining in Japan's huge government debt, which is exceeding 230% of GDP. To help raise government revenue and reduce public debt, Japan decided in 2013 to gradually increase the consumption tax to a total of 10% by the year 2015. Japan is making progress on ending deflation due to a weaker yen and higher energy costs, but reliance on exports to drive growth and an aging, shrinking population pose other major long-term challenges for the economy.

 

Source : CIA

 

 

 

 


Company name and address

 

WAKO PURE CHEMICAL INDUSTRIES LTD

 

REGD NAME:   Wako Junyaku Kogyo KK

MAIN OFFICE:  3-1-2 Doshomachi Chuoku Osaka 540-8605 JAPAN

                        Tel: 06-6203-3741     

Fax: 06-6203-2029

 

URL:                 http://www.wako-chem.co.jp

E-Mail address: (thru the URL)

 

 

ACTIVITIES

 

Mfg of laboratory chemicals, specialty chemicals, chemical diagnostics, reagents

 

 

BRANCHES   

 

Tokyo, Sapporo, Sendai, Shizuoka, Fujisawa, Fukuoka, other (Tot10)

 

 

OVERSEAS   

 

Germany, USA (3), China (2)

 

 

FACTORIES

 

Tokyo, Aichi, Mie, Osaka, Harima, Oita

 

 

OFFICERS

 

SHINZO KOBATAKE, PRES      Takumi Tanaka, s/mgn dir

Toshiro Hanada, s/mgn dir         Tatsuya Kobayashi, mgn dir

Nobuyuki Tokioka, dir                Kazuo Shirki, dir

                       

 


Yen Amount

 

In million Yen, unless otherwise stated

 

 

SUMMARY

 

FINANCES        FAIR                             A/SALES          Yen 71,754 M

PAYMENTS      NO COMPLAINTS          CAPITAL           Yen 2,339 M

TREND             UP                                WORTH            Yen 109,554 M                                     

STARTED         1922                             EMPLOYES      1,490

 

 

COMMENT    

 

MFR OF CHEMICALS.

FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS.

                       

 

HIGHLIGHTS

           

The subject company was established on the basis of a division separated from the then Takeda Chobei Shoten (now Takeda Pharmaceutical Co Ltd) (See REGISTRATION), as Takeda Pure Chemicals Ltd.  Renamed in 1949 as captioned.  This is a special mfr of laboratory chemicals, specialty chemicals, chemical diagnostics, reagents, other.  Clients include universities, hospitals, medical institutions, other, nationwide.

 

 

FINANCIAL INFORMATION

           

The sales volume for Mar/2013 fiscal term amounted to Yen 71,754 million, an almost similar amount of Yen 72,064 million in the previous term.  The recurring profit was posted at Yen 7,195 million and the net profit at Yen 4,660 million, respectively, compared with Yen 7,889 million recurring profit and Yen 4,597 million net profit, respectively, a year ago.

 

For the term that ended Mar 2014 the recurring profit was projected at Yen 7,300 million and the net profit at Yen 4,700 million, respectively, on a 3% rise in turnover, to Yen 74,000 million.  Final results are yet to be released.

 

The financial situation is considered FAIR and good for ORDINARY business engagements. 

 

 

REGISTRATION

 

Date Registered:  Jun 1922

Legal Status:       Limited Company (Kabushiki Kaisha)

Authorized:         133.36 million shares

Issued:                33.34 million shares

Sum:                   Yen 3,339 million

Major shareholders (%): Takeda Pharmaceutical Co Ltd* (69.4), Fujifilm Holdings Corp (9.5)          

No. of shareholders: 604

 

*.. Top-ranked pharmaceutical mfr, Osaka, founded Tokyo S/E, capital Yen 63,562 million, sales Yen 1,557,267 million, operating profit Yen 122,505 million, recurring profit Yen 113,168 million, net profit Yen 131,244 million, total assets Yen 4,253,216 million, net worth Yen 2,281,167 million, employees 31,507, pres Yasuchika Hasegawa

 

Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION

           

Activities: Manufactures reagents (17%), chemicals (laboratory chemicals, specialty chemicals) (22%), clinical diagnostics (31%)

 

Clients: [Mfrs, wholesalers] Takeda Pharmaceutical Co, Fujifilm Holdings, other to universities, laboratories, synthetic resin mfrs, chemical firms, other 

            No. of accounts: 500

            Domestic areas of activities: Nationwide

Suppliers: [Mfrs, wholesalers] Wacoal Chemical, A&T, Miyako Kohsan Co, Chisso Corp, Dojindo Laboratories, other

 

Payment record: No complaints

 

Location: Business area in Osaka.  Office premises at the caption address are owned and maintained satisfactorily.

 

Bank References:

                        SMGC (Osaka)

                        MUFG (Osaka)

                        Relations: Satisfactory

 

 

FINANCES (In Million Yen)

 

       Terms Ending:

31/03/2014

31/03/2013

31/03/2012

31/03/2011

Annual Sales

 

74,000

71,754

72,064

71,790

Recur. Profit

 

7,300

7,195

7,889

8,322

Net Profit

 

4,700

4,660

4,597

5,107

Total Assets

 

 

140,641

136,721

136,351

Current Assets

 

 

107,143

105,200

 

Current Liabs

 

 

22,253

20,473

 

Net Worth

 

 

109,554

107,529

105,626

Capital, Paid-Up

 

 

2,339

2,339

2,339

Div.P.Share(¥)

 

 

81.50

80.00

78.50

<Analytical Data>

(%)

(%)

(%)

(%)

    S.Growth Rate

3.13

-0.43

0.38

-3.48

    Current Ratio

..

481.48

513.85

..

    N.Worth Ratio

..

77.90

78.65

77.47

    R.Profit/Sales

9.86

10.03

10.95

11.59

    N.Profit/Sales

6.35

6.49

6.38

7.11

    Return On Equity

..

4.25

4.28

4.83

 

Notes: Forecast (or estimated) figures for the 31/03/2014 fiscal term.

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.38

UK Pound

1

Rs.101.63

Euro

1

Rs.83.57

 

INFORMATION DETAILS

 

Analysis Done by :

SUM

 

 

Report Prepared by :

NNA

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.